Innovative Tools for Digital Health Evidence Generation
Open-source tools will help developers generate evidence that meets the needs of all decision-makers through integrated evidence plans.
Today, the Digital Medicine Society (DiMe), along with notable partners, announced the launch of new resources aimed at assisting developers of digital health technologies (DHTs) in navigating the complexities of Integrated Evidence Plans (IEP). These tools provide comprehensive support to ensure that developments yield evidence suitable for all stakeholders, ultimately paving the way for commercial success.
In an era marked by shifting regulatory landscapes, it is crucial for DHT developers to embrace an evidence-driven approach. The IEP toolkit introduces a structured and transparent framework that equips innovators with the tools necessary to meet evidentiary requirements, tackle market access challenges, mitigate risks, and foster commercial triumph—creating a straightforward pathway for widespread adoption of DHTs.
This initiative builds upon priorities that emerged from industry assessments, demonstrating the need for harmonizing regulatory expectations with the decision-making processes of buyers and payers. Navigating these aspects becomes essential for the effectiveness and acceptance of DHTs.
Smit Patel, Program Director at DiMe, expressed, "Despite gaining regulatory approval, numerous DHTs encounter barriers to widespread acceptance due to unclear evidence requirements and mismatched strategies. It's essential to address the requirements of downstream stakeholders, including payors and healthcare providers, to ensure commercial viability." He added that the resources made available will create a cohesive and comprehensive strategy that satisfies all parties involved, facilitating a quicker time-to-market and greater uptake of these technologies.
Moreover, DiMe's offerings include vital resources designed to enhance collaboration across the industry, promoting a unified approach to the development of DHTs. Highlights of the newly launched resources include:
- IEP Toolkit: A detailed roadmap for formulating evidence plans, equipping developers with crucial best practices, templates, checklists, and illustrative case studies.
- Stakeholder Map: An essential inventory of decision-makers who influence the adoption of DHTs, detailing their specific needs to foster aligned efforts throughout the product lifecycle.
- High-Quality Evidence Checklist: A vital checklist that ensures developers adhere to high standards when generating evidence, thereby aligning their outputs with the requirements of downstream decision-makers.
Maurice Solomon, Principal at ZS, emphasized the significance of this collaboration: "We're thrilled to work alongside DiMe and a diverse industry team to develop groundbreaking resources that empower all organizations—regardless of their size—to approach evidence generation with a holistic perspective for innovative digital solutions." He stated that these tools provide a strategic framework to navigate the necessary time, cost, and effort involved in producing critical evidence to facilitate the introduction of new digital tools to clinicians and patients effectively.
DiMe is at the forefront of multiple significant projects that focus on optimizing digital measures to ensure the safe and efficient application of digital technologies while enhancing patients' quality of life. Current efforts include ongoing work in continuous glucose monitoring aimed at enhancing market accessibility for effective diabetes treatments, as well as initiatives to establish robust digital measures for prevalent mental health conditions, which will expand the use of quantifiable, scalable endpoints for evaluating treatment outcomes.
About DiMe: DiMe is a global non-profit organization that serves as the hub for professionals engaged in digital medicine. Its mission is to address the complex challenges faced in this field, develop practical clinical resources over time, and disseminate these essential tools through open-source platforms and educational outreach.
Media Contact: Carla English, [Contact Email]
Frequently Asked Questions
What are Integrated Evidence Plans (IEP)?
IEPs are structured frameworks that help developers of digital health technologies align their evidence generation with the needs of stakeholders, including payors and healthcare providers.
Who is the Digital Medicine Society (DiMe)?
DiMe is a non-profit organization dedicated to supporting the digital medicine community by tackling challenges, developing resources, and providing educational programs.
What resources has DiMe launched for digital health technologies?
DiMe has introduced an IEP toolkit, a stakeholder map, and a checklist for high-quality evidence, which help developers create evidence that meets regulatory and stakeholder needs.
Why is evidence generation important for digital health technologies?
Generating appropriate evidence is essential for ensuring the acceptance and adoption of digital health technologies in the market, leading to improved healthcare outcomes.
How can digital health technologies improve patient care?
Digital health technologies can enhance patient care by providing timely information, monitoring health conditions effectively, and facilitating personalized treatment options based on data-driven insights.
